Oxfendazole Development Group's annual revenue was $9K in tax year 2025, reported on their IRS Form 990. They spent $227K in total expenses. 99% went to programs and services.
Oxfendazole Development Group spent $227K in tax year 2025, according to their IRS Form 990 filing.
Oxfendazole Development Group spent $225K (99% of expenses) on programs and services in tax year 2025.
Oxfendazole Development Group's overhead in tax year 2025 includes administrative (1%) and fundraising (0%) of their expenses.
Oxfendazole Development Group had net assets of $100K as of the end of tax year 2025.
Track Oxfendazole Development Group
Follow to get their new filings, financial changes and grants as they post.
Leave your email and we’ll let you know when you can finish signing in and follow the organization.
Try signing in anyway →